NRXS

NRXS

USD

Neuraxis Inc. Common Stock

$2.540-0.120 (-4.511%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.660

最高

$2.630

最低

$2.520

交易量

0.12M

公司基本面

市值

25.4M

行業

生物科技

國家

United States

交易統計

平均交易量

0.38M

交易所

ASE

貨幣

USD

52週範圍

最低 $1.33當前 $2.540最高 $6.2

相關新聞

GlobeNewswire

NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025

CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating

查看更多
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
GlobeNewswire

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population

Achieves significant expansion of NeurAxis' total addressable marketClearance now includes patients aged "8 years and older"Expanded age indication will utilize the upcoming January 1st, 2026, Category I CPT code to

查看更多
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population